1. Home
  2. CABR vs ADVB Comparison

CABR vs ADVB Comparison

Compare CABR & ADVB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

CABR

Caring Brands Inc.

N/A

Current Price

$1.33

Market Cap

12.1M

ML Signal

N/A

ADVB

Advanced Biomed Inc.

N/A

Current Price

$4.62

Market Cap

10.1M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
CABR
ADVB
Founded
2020
2014
Country
United States
United States
Employees
3
31
Industry
Package Goods/Cosmetics
Medical Specialities
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
12.1M
10.1M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
CABR
ADVB
Price
$1.33
$4.62
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
82.4K
31.6K
Earning Date
05-15-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$1.26
Revenue Growth
N/A
N/A
52 Week Low
$0.71
$0.19
52 Week High
$1.65
$7.70

Technical Indicators

Market Signals
Indicator
CABR
ADVB
Relative Strength Index (RSI) 57.25 54.89
Support Level $0.80 $4.50
Resistance Level $1.35 $5.83
Average True Range (ATR) 0.13 0.64
MACD 0.01 0.10
Stochastic Oscillator 54.55 44.88

Price Performance

Historical Comparison
CABR
ADVB

About CABR Caring Brands Inc.

Caring Brands Inc is a wellness consumer products company. It offers several over-the-counter (OTC) and cosmetic consumer products. Its product pipeline includes a diverse products, such as hair loss treatments, eczema and psoriasis treatments, vitiligo solutions, a jellyfish sting protective suncare line, and women's sexual wellness products, catering to diverse health and wellness needs. It operates in a single segment.

About ADVB Advanced Biomed Inc.

Advanced Biomed Inc operates through its subsidiaries and is mainly engaged in the research and development of various original microfluidic biochip technologies and the provision of tumor precision diagnosis and treatment technology applications. Through the joint application of semiconductor technology and biotechnology, it has developed various technologies and testing equipment for early screening and detection, diagnosis and staging, and treatment of cancer. Its devices: A+Pre, AC-1000, A+CellScan, and A+SCDrop, and three corresponding microfluidic biochips, A+Pre Chip and AC-1000 CTC Enrichment Chip, and A+CellScan Chip, are designed to provide rapid and affordable assay products and services to cancer patients.

Share on Social Networks: